Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 11/20 | 0.60 |
| ▸ | MME | P08473 | 5/20 | 0.60 |
| ▸ | CPA1 | P15085 | 4/20 | 0.60 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.60 |
| ▸ | CTSD | P07339 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29822653 | 0.92 | ACE (0.59) | ACEMMECPA1ACE2OPRM1 | |
| SCHEMBL11799067 | 0.91 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL18699897 | 0.91 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL17274195 | 0.91 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL11798519 | 0.91 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL29876711 | 0.90 | ACE (0.58) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30158408 | 0.90 | ACE (0.61) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL31318683 | 0.90 | ACE (0.57) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL30123092 | 0.89 | MME (0.51) | ACEMMECPA1ACE2CTSD | |
| SCHEMBL31720934 | 0.89 | ACE (0.56) | ACEMMECPA1ACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2181 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116462741-B | Agglutination polypeptide and application thereof | 中山大学附属口腔医院 | 2023-11-17 | — | — | CN | claimed |
| CN-116462741-A | Agglutination polypeptide and application thereof | 中山大学附属口腔医院 | 2023-07-21 | — | — | CN | claimed |
| CN-122080238-A | RBoNT recombinant protein and precursor thereof, and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-114080232-B | Extracellular vesicles for vaccine delivery | Lhasa Sales Co.,Ltd. (CH) | 2026-05-26 | — | — | CN | disclosed |
| CN-115925966-B | Recombinant thyroid stimulating hormone receptor protein, preparation method and application | 厦门英博迈生物科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-113853432-B | Novel polypeptides for producing patchoulol and/or drimenol compounds | 弗门尼舍有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-112752837-B | Natural killer cells | 帝国理工学院创新有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-117285644-B | Phase change regulating element and application thereof | 清华大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-113121668-B | PEG modified polypeptide capable of inhibiting gp96, preparation method and application thereof | 北京康明海慧生物科技有限公司 | 2026-02-27 | — | — | CN | disclosed |
| EP-4689177-A1 | NOVEL METHOD FOR ISOTHERMAL AMPLIFICATION OF PADLOCK PROBES FOR NUCLEIC ACID DETECTION AND PHI29 DNA POLYMERASE VARIANTS | Consejo Superior De Investigaciones Científicas (ES) | 2026-02-11 | — | — | EP | disclosed |
| US-20250352620-A1 | COMBINATION THERAPY TO TREAT BRAIN CANCER | INOVIO PHARMACEUTICALS INC (US) | 2025-11-20 | — | — | US | disclosed |
| CN-114008197-A | Metabolic engineering for simultaneous consumption of xylose and glucose to produce chemicals from second generation sugars | 布拉斯科公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-114008069-A | Compositions of exosomes and AAV | 科迪亚克生物科学公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113993989-A | Process for producing ergothioneine | 丹麦科技大学 | 2022-01-28 | — | — | CN | disclosed |
| CN-113993898-A | Human antibodies that bind RET and methods of use thereof | 瑞泽恩制药公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-110066810-B | Tamarix chinensis plasma membrane Na+/H+Antiporter gene and application thereof | 南京农业大学 | 2022-01-25 | — | — | CN | disclosed |
| CN-107847615-B | TPP1 formulations and methods for treating CLN2 disease | 生物马林药物股份有限公司 | 2022-01-25 | — | — | CN | disclosed |
| CN-113957088-A | Artificial design and application of intercellular communication system | 中国科学院微生物研究所 | 2022-01-21 | — | — | CN | disclosed |
| CN-107586340-B | Bispecific antibodies specific for T cell activating antigens and tumor antigens and methods of use | 罗切格利卡特公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-113957061-A | Administration of kynurenine depleting enzymes for tumor therapy | 得克萨斯大学体系董事会 | 2022-01-21 | — | — | CN | disclosed |